United States Federal Circuit
Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals LP, 2011-1091
In an appeal from entry of summary judgment in favor of the defendants in a patent infringement dispute, judgment is affirmed because the district court correctly concluded that subject drug formulation satisfied the requirements for prior invention under 35 U.S.C. section 102(g)(2).
Appellate Information
- Decided 12/01/2011
- Published 12/01/2011
Judges
- LINN
Court
- United States Federal Circuit